CONTACT US PRIVATE ACCESS SPINEWAY USA LANGUAGES Home Company Products News Investors INVESTORS DEAR SHAREHOLDERS Ever since Spineway was created in 2005, we have aimed to position our offer at the heart of the spinal implant market. Our experience and thorough knowledge of this market have enabled us to propose solutions which perfectly meet the needs of our clients and to ensure company profitability from the beginning. After seven years of uninterrupted and profitable growth, a range which covers 90% of spinal column pathologies and a network installed in over 30 countries, we have made another step forward by launching Spineway on the Paris Euronext Growth Stock Exchange. With this operation, we have chosen to provide the company with new financial power which will support the continuation of our winning strategy. Our market is international. Our type of surgery is becoming increasingly available in all types of economies and worldwide needs are growing. With our “Gold Standard” products, we have conquered our place and gradually installed our own innovations. This is the fruit of close collaboration between our engineers and the surgeons who design the implants, as well as the result of our insistence on quality and service to our clients. By successfully going public, we now have the means which will enable us to grow the deployment of our innovations and to continue reinforcing our world position We would like to thank all our shareholders for their confidence in us, as well as our teams, who, through their continued efforts, enable us to meet new challenges and continue moving forward successfully. A MESSAGE FROM OUR PRESIDENT (FRENCH) JANUARY 2019 KEY FACTS Value chain made in France 14 families of patents. A range of devices and services that meet 90% of daily operating needs 8 lines of gold standard products. A presence over 30 countries via distributors, over 95% of sales for export. Feb 2013 : Introduction (IPO) on Paris stock exchange (Alternext/euronext). Awarded Rhone Alpes INPI (French Institute of Intellectual Property) for our intellectual property policy. Over 75,000 patients treated with Spineway devices. COMPANY Presentation Why Spineway Recruitment Privacy Policy PRODUCTS MIS and Open Thoracolumbar Arthrodesis mont blanc MIS Open Thoracolumbar Arthrodesis mont blanc mont blanc 3D+ mont blanc baby Open Lumbar Arthrodesis twin peaks PLIF twin peaks OLIF twin peaks TLIF kili Open Cervical Athrodesis ayers rock blue mountain Biomaterials sonora NEWS Event Agenda Blog #Askourleaders INVESTORS Message of the Management About the Company Press releases Schedule Share Price Regulated Information Contact FOLLOW US © Copyright 2020 - Spineway France This web site uses cookies for a better experience. You can manage your cookie preferences by clicking COOKIE SETTINGS or ACCEPT